Bill of Lading No.
Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
KWLD70330045324
2021-04-14
642800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERTUCT CODE NO. 64 G C A 28 H. T. S NO. 3006.6 0.00.00 ANDA NO.210264 THERAPEUTIC . .<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3378
KG
17
PKG
0
USD
MAEU216471482
2022-03-09
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER CONTAINER 45 PALLETS CONSISTING OF 282 1 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERTS USP 10MCG 8 S NDC CODE: 68 462071171 FDA PRODUCT CODE NO .: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:21026 4 THERAPEUTICE USE:THE TREAT MENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. GABAPENTIN TA BLETS 600MG 500 S NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT NAPROXEN TAB LETS 500MG 500 S NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200556 6 DT. 07.02.2022 F2225200556 7 DT. 07.02.2022 F2225200556 8 DT. 07.02.2022 TOTAL NET.W T. 11031.92KGS SBILL NO 808 1445 DT 08-FEB-2022 8081704 D T 08-FEB-2022 8081645 DT 08-F EB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12738
KG
45
PKG
0
USD
MAEU914081948
2022-04-20
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 41 PALLETS 1568 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS USP 10MCG 1 8 S NDC CODE:68462071188 NDC NO.:68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO .:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINI TIS DUE TO MENOPAUSE. DESM OPRESSIN ACETATE TABLETS 0.2MG 100S NDC CODE:68462027601 F DA PRODUCT CODE NO.: 61QCA03 H. T. S NO.: 2937.19.0000 A NDA NO.:201831 THERAPEUTICE U SE: - MANAGEMENT OF CENTRAL DIABETES INSIPIDUS AND TEMPOR ARY POLYURIA AND POLYDIPSIA ASHLYNA LEVO/EE 0.15/0.03MG 182 NDC CODE:68462064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 203163 THERAPEUTICE USE: - INDICATED FOR USE BY WOMEN TO PREVENT PREGNANCY GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22252006158 DT. 22.03.2 022 F22252006148 DT. 21.03.20 22 F22252006153 DT. 21.03.202 2 S/BILL NO: 9120133 DT:22-MA R-22 S/BILL NO: 9120061 DT :22-MAR-22 S/BILL NO: 9120267 DT:22-MAR-22 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NET WT.: 9,712.12 KGS NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11046
KG
41
PKG
0
USD
KWLD70330058676
2021-10-07
642800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN CODE68462071188 NDC NO.68462071188 FDA PROD UCT CODE NO. 64 G C A 28 H. T. S NO. 3006.6<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6213
KG
1578
CTN
0
USD
MAEU214625872
2021-12-08
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER CONT AINER 10 PALLETS CONSISTING OF 199 CARTONS PHARMACEUTICA LS AS UNDER FLUOCINONIDE CREAM 0.1% 120GM NDC CODE:68 462050566 FDA PRODUCT CODE N O.: 64 L C L 28 H. T. S NO .: 3004.32.00.00 ANDA NO.: 91-282 THERAPEUTICE USE: - INDICATED FOR THE RELIEF OF VARIOUS INFLAMMATORY AND P RURITIC MANIFESTATIONS OF CO RTICOSTEROID RESPONSIVE DERM ATOSES IN PATIENTS. FLUOCI NONIDE CREAM 0.1% 60GM NDC C ODE:68462050565 FDA PRODUCT CODE NO.: 64 L C L 28 H. T . S NO.: 3004.32.00.00 AND A NO.: 91-282 THERAPEUTICE U SE: - INDICATED FOR THE RELI EF OF VARIOUS INFLAMMATORY A ND PRURITIC MANIFESTATIONS O F CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS. CLOBETASOL PROP SOLUTION 0. 05% 50ML NDC CODE:6846205325 3 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOC ORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQ UID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) HYDROC ORTISONE VAL OINTMENT 0.2% 15G M NDC CODE:68462083617 FDA PRODUCT CODE NO.: 64 L C L 71 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 211750 THERA PEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMAT ORY AND PRURITIC MANIFESTATI ONS OF CORTICOSTEROID RESPON SIVE DERMATOSES IN ADULT P ATIENTS 07 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222350 02998 DT. 31.10.2021 F222350 03000 DT. 31.10.2021 F222350 03004 DT. 31.10.2021 TOTAL G R.WT.:1796.71KGS TOTAL NT.WT .:922.56 KGS SBILL NO. DT. 5825919 05-11 -21 5825940 05-11-21 5 797455 03-11-21 NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1797
KG
10
PKG
0
USD
MAEU218466073
2022-06-08
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 1716 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS USP 10MCG 1 8 S NDC CODE:68462071188 NDC NO.:68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO .:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINI TIS DUE TO MENOPAUSE. ESTR ADIOL VAG INSERTS USP 10MCG 8 S NDC CODE:68462071171 FDA P RODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. ESTRADIOL VAG INSERTS USP 1 0MCG 8 S NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60. 00.00 ANDA NO.:210264 THERAP EUTICE USE:THE TREATMENT OF A TROPIC VAGINITIS DUE TO MENO PAUSE. NORGEST/EE 0.25/0.03 5MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 200538 THERAPE UTICE USE: - ORAL CONTRACEPTI VES INV NO: F22352000401 DT. 30.04.2022 INV NO: F22352 000472 DT. 06.05.2022 INV NO: F22352000473 DT. 06.05.2022 S/BILL NO:1279038 DT: 09/05/20 22 S/BILL NO:1276595 DT:09/05 /2022 S/BILL NO:1276586 DT: 09/05/2022 NET WT: 4,528.6 1 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5935
KG
40
PKG
0
USD
MAEU214629272
2021-12-08
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER CONT AINER 24 PALLETS CONSISTING OF 695 CARTONS PHARMACEUTICA LS AS UNDER ESTRADIOL VAG IN SERTS USP 10MCG 18 S NDC COD E:68462071188 NDC NO.:684620 71188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITIS DUE T ESTRADIOL VAG INSE RTS USP 10MCG 18 S NDC CODE: 68462071188 NDC NO.:68462071 188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3 006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREA TMENT OF ATROPIC VAGINITIS D UE TO MENOPAUSE. LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUC T CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AN DA NO.:206498 THERAPEUTICE U SE: -USED TO TEMPORARILY REL IEVE PAIN AND ITCHING ASSO CIATED WITH SKIN 05 DAT A LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22252004069 DT. 03.11.2 021 F22252004070 DT. 03.11.2 021 F22252004074 DT. 03.11.2 021 SBILL NOS DT. 5827009 0 5-NOV-21 5827010 05-NOV-21 5 828596 05-NOV-21 TOTAL G R.WT.:3828.18 KGS TOTAL NT.W T:3058.16 KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3828
KG
24
PKG
0
USD
MEDUMG836726
2020-12-02
642800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 10 PALLET CONTAINING 418 C ARTONS PHARMACEUTICALS AS UNDER FLUOCINONIDE CREAM 0 .1% 120GM NDC CODE:6846205 0566 FDA PRODUCT CODE NO.: 64 L C L 28 H. T. S NO.:30 04.32.00.00 ANDA NO.: 91-2 82 THERAPEUTICE USE: -INDI CATED FOR THE RELIEF OF VA RIOUS INFLAMM
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1673
KG
10
PKG
0
USD
MEDUMV093452
2020-08-06
642800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 40 PALLETS CONTAINING 1586 CARTONS PHARMACEUTICALS A S UNDER ESTRADIOL VAG INSE RTS USP 10MCG 18 S NDC COD E:68462071188 NDC NO.:6846 2071188 FDA PRODUCT CODE N O.: 64 G C A 28 H. T. S NO .: 3006.60.00.00 ANDA NO.: 210264 THERAPEUTICE USE:TH E TREATMENT O
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6160
KG
40
PKG
0
USD
IGLBMU13463NHNYC
2022-02-25
642800 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LTD 33 PACKAGES CONTAINING 1708 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERTS USP 10MCG 8S NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 A NDA NO.:210264 THERAPEUTICE USE:THE TREATMENTOF ATROPIC VAGINITIS DUE TO MENOPAUSE. LEVON ORGESTRELEE 0.150.03MG 273 NDC CODE:68462067 295 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. SNO.: 3006.60.0000 ANDA NO.: 203164 THERAPEU TICE USE: - CONTRACEPTION TO PREVENT PREGNANCY 01 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : 20 DEGREES<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5222
KG
33
PKG
0
USD
MAEU608906311
2022-03-02
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER PHARMACEUTI CALS 41 PALLETS CONSISTING OF 2446 CARTONS AS UNDER ES TRADIOL VAG INSERTS USP 10 MCG 8 S NDC CODE: 68462071 171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. DESMOPR ESSIN ACETATE TABLETS 0.2M G 100S NDC CODE:68462027601 FDA PRODUCT CODE NO.: 61QC A03 H. T. S NO.: 2937.19.0 000 ANDA NO.:201831 THERAP EUTICE USE: - MANAGEMENT OF CENTRAL DIABETES INSIPIDUS A ND TEMPORARY POLYURIA AND POLYDIPSIA DROSPIRENONE/EE 3.0/0.03MG 84 NDC CODE: 6 8462073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S N O.: 3006.60.00.00 ANDA NO. : 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY 03 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES COMMERCIAL & CUSTOM INVOICE NO. F22252005475 D T. 31.01.2022 F22252005489 DT. 31.01.2022 F22252005495 DT. 31.01.2022 TOTAL NET WT. :5174.25KGS SBILL NOS. DT. 7934626 DT 02-F EB-2022 7934341 DT 02-FEB-202 2<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6916
KG
41
PKG
0
USD
KWLD70330059198
2021-10-05
642800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 1X40 RH STC 1762 CARTONS PACKED IN 21 PACKAGERTS USP 10MCG 8 S NDC CODE68462071171 FDA PR ODUCT CODE NO. 64 G C A 28 H. T. S<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4477
KG
1762
CTN
0
USD
MEDUMA315529
2020-12-23
642800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 7 PALLET CONTAINING 482 CA RTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INS ERTS USP 10MCG8 S NDC COD E:68462071171 FDA PRODUCT CODE N O.: 64 G C A 28 H. T . S NO.:3006.60.00.00 ANDA NO.:210264 THERAPEUTICE U SE:THE TREATMENTOF ATROPI C VAGINITIS DUE TO M
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1227
KG
7
PKG
0
USD
MAEU217545827
2022-04-27
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 25 PALLETS 1630 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERT S USP 10MCG 8 S NDC CODE:6846 2071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3 006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREATME NT OF ATROPIC VAGINITIS DUE T O MENOPAUSE. VIORELE DESO/ EE-EE .15/.02-.01MG 84 NDC CO DE:68462031829 FDA PRODUCT CO DE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE: - O RAL CONTRACEPTIVES LEVONOR GESTREL/EE 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO .: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PREGN ANCY NORETHINDRONE ACE/EE T AB 0.5MG/2.5MCG 84 NDC CODE:6 8462065629 FDA PRODUCT CODE N O.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203 038 THERAPEUTICE USE: - TREA TMENT OF MODERATE TO SEVERE V ASOMOTOR SYMPTOMS DUE TO MEN OPAUSE; OSTEOPOROSIS PREVENTI ON NORETHINDRONE ACE/EE TAB S 1/0.005MG 90 NDC CODE:68462 065790 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMEN T OF MODERATE TO SEVERE VASOM OTOR SYMPTOMS DUE TO MENOPAU SE; OSTEOPOROSIS PREVENTION COMMERCIAL & CUSTOM INVOICE NO. F22252006289 DT. 30.03.20 22 F22252006339 DT. 31.03.202 2 F22252006368 DT. 31.03.2022 S/BILL NO: 9426141 DT:01-APR -22 S/BILL NO: 9426027 DT:01- APR-22 S/BILL NO: 9426166 DT: 01-APR-22 NET WT. 3,369.64 KG S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4437
KG
25
PKG
0
USD